ClinicalTrials HQ

University of Calgary

University of Calgary

Calgary, Alberta, Canada

31 results · Page 1 of 2

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Assess How Well and Safely Elafibranor Works in Adult Participants With Primary Sclerosing CholangitisCholangitis, Sclerosing, Digestive System Diseases, bile duct disorder, biliary tract disorder, cholangitis, primary sclerosing cholangitisRecruitingPhase 32026-10-01NCT07387549
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasisbronchial disorder, bronchiectasis, respiratory system disorderRecruitingPhase 32026-10-01NCT06872892
A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants With Primary Sclerosing Cholangitis.Cholangitis, Sclerosing, Digestive System Diseases, bile duct disorder, biliary tract disorder, cholangitis, primary sclerosing cholangitisActive, not recruitingPhase 22026-10-01NCT05627362
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKEbrain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorderActive, not recruitingPhase 32026-09-25NCT05702034
Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD)Crohn disease, Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitisRecruitingNot stated2026-08-31NCT07245394
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and ObesityBody Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, cardiovascular disorder, heart disorder, heart failure, nutritional disorder, obesity disorder, overnutritionRecruitingPhase 32026-08-18NCT07567001
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR VariantAlzheimer disease, Amyloid Neuropathies, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Nutritional and Metabolic Diseases, amyloidosis, brain disorder, cardiomyopathy, cardiovascular disorder, central nervous system disorder, cognitive disorder, dementia, familial amyloid neuropathy, heart disorder, hereditary amyloidosis, hereditary disease, inborn errors of metabolism, inherited neurodegenerative disorder, metabolic disease, nervous system disorder, neurodegenerative disease, neuromuscular disease, peripheral nervous system disorder, polyneuropathy, proteostasis deficiencies, psychiatric disorder, tauopathyRecruitingPhase 32026-08-04NCT06563895
A Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Muscular Disorders, Atrophic, hereditary disease, inherited neurodegenerative disorder, muscle tissue disorder, muscular dystrophy, musculoskeletal system disorder, myotonic dystrophy, myotonic syndrome, nervous system disorder, neurodegenerative disease, neuromuscular diseaseRecruitingPhase 22026-07-29NCT06667453
An Innovative Master Platform for Clinical Trials in Mood DisordersBipolar and Related Disorders, depressive disorder, mood disorder, psychiatric disorderRecruitingNot stated2026-07-13NCT06408012
Stopping Aminosalicylate Therapy in Inactive Crohn's DiseaseCrohn disease, Digestive System Diseases, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorderActive, not recruitingPhase 42026-05-28NCT03261206
CAlgary SAlt for POTSautonomic nervous system disorder, nervous system disorder, orthostatic intolerance, primary dysautonomiaRecruitingNot applicable2026-05-07NCT05924646
NC Testing in LC & POTSCOVID-19, Chronic Disease, Coronaviridae Infections, Disease Attributes, Fatigue, Infections, Mental Fatigue, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Post-Infectious Disorders, RNA Virus Infections, Signs and Symptoms, autonomic nervous system disorder, long COVID-19, lung disorder, nervous system disorder, orthostatic intolerance, pneumonia, primary dysautonomia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumoniaRecruitingNot applicable2026-05-07NCT05914649
Compression Garments in the Community With POTSautonomic nervous system disorder, nervous system disorder, orthostatic intolerance, primary dysautonomiaRecruitingNot applicable2026-05-07NCT04881318
Hypercapnia and Orthostatic Tolerance in Postural Orthostatic Tachycardia SyndromeNeurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, autonomic nervous system disorder, nervous system disorder, orthostatic intolerance, primary dysautonomiaRecruitingNot applicable2026-05-07NCT04271878
Assessing Systemic Circulation and LV Performance in Adultscardiovascular disorder, heart disorder, heart failureRecruitingNot applicable2026-05-05NCT04347655
Assessment of Stroke Volume and Cardiac Output in Response to Varying Heart RatesConsciousness Disorders, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Syncope, Syncope, Vasovagal, Unconsciousness, autonomic nervous system disorder, nervous system disorder, orthostatic intolerance, primary dysautonomiaRecruitingNot applicable2026-05-05NCT03446326
POTS Adrenergic Ab (CIHR Aims #1&2)autonomic nervous system disorder, nervous system disorder, orthostatic intolerance, primary dysautonomiaRecruitingNot stated2026-05-05NCT02673996
The Need for Repeat ERCP After Endoscopic Treatment of Postsurgical Biliary LeaksBile LeakActive, not recruitingNot stated2026-04-29NCT05141942
Optimizing the Evaluation and Management of Patients With Suspected CholedocholithiasisDigestive System Diseases, bile duct disorder, biliary tract disorder, choledocholithiasis, cholelithiasis, common bile duct disorder, gallbladder disorderRecruitingNot stated2026-04-29NCT05141916
Calgary Registry for Advanced and Therapeutic EndoscopyDigestive System Diseases, biliary tract disorder, gallbladder disorder, pancreas disorderRecruitingNot stated2026-04-29NCT04259580
Body Surface Gastric Mapping to Evaluate Patients With Upper Gastrointestinal Symptoms and ControlsChemically-Induced Disorders, Digestive System Diseases, Familial cyclic vomiting syndrome, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, cannabinoid hyperemesis syndrome, cannabis dependence, digestive system disorder, gastroparesis, palsy, psychiatric disorder, stomach disorder, substance-related disorderEnrolling by invitationNot stated2026-04-24NCT05812339
A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, autoimmune disease, autoimmune disorder of the nervous system, chronic inflammatory demyelinating polyradiculoneuropathy, demyelinating disease, immune system disorder, nervous system disorder, neuromuscular disease, peripheral nervous system disorder, polyneuropathy, polyradiculoneuropathyRecruitingPhase 22026-04-23NCT06798012
An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)Nutritional and Metabolic Diseases, amyloidosis, metabolic disease, proteostasis deficienciesEnrolling by invitationPhase 32026-04-17NCT05667493
AMX0114 in Adult Participants With Amyotrophic Lateral SclerosisNutritional and Metabolic Diseases, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, spinal cord disorderRecruitingPhase 12026-04-14NCT06665165
An Open-Label Extension Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1 (FREEDOM-OLE)Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Muscular Disorders, Atrophic, hereditary disease, inherited neurodegenerative disorder, muscle tissue disorder, muscular dystrophy, musculoskeletal system disorder, myotonic dystrophy, myotonic syndrome, nervous system disorder, neurodegenerative disease, neuromuscular diseaseRecruitingPhase 22026-03-30NCT07220603